| Pancreatic cancer surgery: the new R-status counts O Strobel, T Hank, U Hinz, F Bergmann, L Schneider, C Springfeld, ... Annals of surgery 265 (3), 565-573, 2017 | 364 | 2017 |
| Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories O Strobel, U Hinz, A Gluth, T Hank, T Hackert, F Bergmann, J Werner, ... Annals of surgery 261 (5), 961-969, 2015 | 221 | 2015 |
| T cells armed with CXC chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours S Lesch, V Blumenberg, S Stoiber, A Gottschlich, J Ogonek, BL Cadilha, ... Nature biomedical engineering 5 (11), 1246-1260, 2021 | 137 | 2021 |
| Prognostic factors of survival after neoadjuvant treatment and resection for initially unresectable pancreatic cancer U Klaiber, ES Schnaidt, U Hinz, MM Gaida, U Heger, T Hank, O Strobel, ... Annals of surgery 273 (1), 154-162, 2021 | 127 | 2021 |
| Association between pancreatic fistula and long-term survival in the era of neoadjuvant chemotherapy T Hank, M Sandini, CR Ferrone, C Rodrigues, M Weniger, M Qadan, ... JAMA surgery 154 (10), 943-951, 2019 | 108 | 2019 |
| Actual five-year survival after upfront resection for pancreatic ductal adenocarcinoma: who beats the odds? O Strobel, P Lorenz, U Hinz, M Gaida, AK Koenig, T Hank, W Niesen, ... Annals of surgery 275 (5), 962-971, 2022 | 104 | 2022 |
| Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma I Poschke, M Faryna, F Bergmann, M Flossdorf, C Lauenstein, J Hermes, ... Oncoimmunology 5 (12), e1240859, 2016 | 103 | 2016 |
| Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail T Hank, U Hinz, I Tarantino, J Kaiser, W Niesen, F Bergmann, T Hackert, ... Journal of British Surgery 105 (9), 1171-1181, 2018 | 94 | 2018 |
| Oncological outcome of conversion surgery after preoperative chemotherapy for metastatic pancreatic cancer T Hank, U Klaiber, U Hinz, D Schütte, CS Leonhardt, F Bergmann, ... Annals of Surgery 277 (5), e1089-e1098, 2023 | 77 | 2023 |
| Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability C Jäkel, F Bergmann, R Toth, Y Assenov, D Van Der Duin, O Strobel, ... Nature communications 8 (1), 1323, 2017 | 62 | 2017 |
| Local radicality and survival outcome of pancreatic cancer surgery W Niesen, T Hank, M Büchler, O Strobel Annals of Gastroenterological Surgery 3 (5), 464-475, 2019 | 56 | 2019 |
| An elevated CA 19-9 is associated with invasive cancer and worse survival in IPMN D Ciprani, V Morales-Oyarvide, M Qadan, T Hank, M Weniger, ... Pancreatology 20 (4), 729-735, 2020 | 51 | 2020 |
| Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1 PY Tsai, MS Lee, U Jadhav, I Naqvi, S Madha, A Adler, M Mistry, ... Proceedings of the National Academy of Sciences 118 (10), e2003014118, 2021 | 49 | 2021 |
| Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer M Weniger, T Hank, M Qadan, D Ciprani, T Michelakos, H Niess, ... British Journal of Surgery 108 (6), 709-716, 2021 | 47 | 2021 |
| Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer MA Schirmer, CM Lüske, S Roppel, A Schaudinn, C Zimmer, R Pflüger, ... Journal of the National Cancer Institute 108 (5), djv387, 2016 | 42 | 2016 |
| IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy J Kaiser, C Scheifele, U Hinz, CS Leonhardt, T Hank, AK Koenig, ... European Journal of Surgical Oncology 48 (6), 1309-1320, 2022 | 41 | 2022 |
| Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas C Rodrigues, T Hank, M Qadan, D Ciprani, M Mino-Kenudson, ... Pancreatology 20 (4), 722-728, 2020 | 37 | 2020 |
| Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer T Hank, M Sandini, M Qadan, M Weniger, D Ciprani, A Li, CR Ferrone, ... Pancreatology 20 (1), 125-131, 2020 | 37 | 2020 |
| Risk of malignancy in small pancreatic cysts decreases over time D Ciprani, M Weniger, M Qadan, T Hank, NK Horick, JM Harrison, ... Pancreatology 20 (6), 1213-1217, 2020 | 33 | 2020 |
| Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges J Michael Harnoss, M Johannes Strowitzki, P Radhakrishnan, ... Hypoxia, 1-14, 2015 | 31 | 2015 |